More Chimeric Therapeutics Limited news Chimeric Therapeutics LimitedASX: CHM CHM CDH17 Phase 1/2 clinical trial approved for initiation May 20, 2024 at 3:21 AM UTC As issuedPlain English Chimeric Therapeutics Ltd has released a press release. View Attachment
